Back to top

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

Fidelity Select Biotechnology Pt: (MF: FBIOX)

(MF) As of Nov 21, 2014 06:05 PM ET

 Add to portfolio

$231.73 USD

+0.92 (0.40%)

Zacks MF Rank : 4 - Sell [?]       4  

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

General Information as of Oct 31, 2014

% Yield 0.00
% SEC Yield NA
% YTD Return (as of Oct 31, 2014) 28.73
Objective Sector - Health
Peer HL MG

Zacks Premium Research for FBIOX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?] Rank Change Trend Sell 4
MF Research Report

( = Change in last 30 days)

Zacks Mutual Fund #1 Ranked Funds

View the Zacks Mutual Fund Rank Guide

Portfolio Statistics

%Unrealized Gain YTD 35.63
Net Assets (Mil $) 10/31/2014 9,165.61
%Turnover 10/31/2014 35.00

Allocation

% of Portfolio
Large Growth 26.09
Large Value 0.00
Small Growth 36.56
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 0.00
Foreign Bond 0.00
High Yield Bond 0.00

Sector / Country Weightings

As of 10/31/2014 % of Portfolio
Health 55.03
Services 24.32
Other 17.86
Industrial Cyclical 2.52
Technology 0.27

Portfolio Holdings

Top Equity Holdings
(As of 8/31/2014)
% of Portfolio Value (Mil$)
GILEAD SCIENCES INC 13.24 1,221.79
VERTEX PHARMACEUTICALS IN 5.41 498.86
CELGENE CORP 4.70 433.41
REGENERON PHARMACEUTICALS 3.98 367.23
ALEXION PHARMACEUTICALS I 3.82 351.98
~INTERCEPT PHARMACEUTICAL 3.65 336.82
PUMA BIOTECHNOLOGY INC 3.40 313.82
MEDIVATION INC 2.41 222.10
BIOGEN IDEC INC 1.82 168.16

Stock Holding % of Net Assets

As Of 8/31/2014
Total Issues 196
Avg. P/E 41.26
Avg. P/Book 5.79
Avg. EPS Growth 15.45
Avg. Market Value (Mil $) 36,457

Risk

3 Year 5 Year 10 Year
Beta 1.12 1.02 0.80
Alpha 21.13 16.08 10.34
R Squared 0.23 0.41 0.34
Std. Dev. 21.33 20.86 20.34
Sharpe 2.27 1.75 2.00